This highly interactive 3-hour virtual course brings together R&D executives from pharmaceutical and biotechnology companies, contract service and technology providers to examine alliance management strategies and practices that optimize drug development planning and execution.
Group Rates: Access to this rate requires 3 or more participants. Special Rates: Only eligible when an active special is going on.
Recent research exploring workplace diversity, equity, and inclusion (DEI) dynamics has demonstrated the damaging impact that exclusionary acts can have on team dynamics and employee outcomes among drug development professionals. Given the interdisciplinary and collaborative nature of drug development, not addressing these dynamics can have costly consequences in the form of reduced team morale and trust, decreased productivity, and eventual turnover.
Global Biotech E-Sourcebook — a fully searchable, comprehensive database on the biotechnology industry capturing its rapid growth and change during the period 2001-2020. The E-Sourcebook includes benchmarks and detailed financial, economic and trend data on more than 440 products; 325 biotech and leading pharmaceutical companies. Ideal for strategic and R&D planning, financial and economic analyses, market intelligence, M&A and investment analysis, regulatory and pipeline tracking.